title: Combination treatment of acute myeloblastic leukemia with rhGM-CSF and standard induction chemotherapy.
authors: First Medical Department, University of Vienna, Austria.
authors: P
authors: P
authors: Valent
authors: C
authors: C
authors: Sillaber
authors: K
authors: K
authors: Geissler
authors: M
authors: M
authors: Andreeff
authors: A
authors: A
authors: Tafuri
authors: L
authors: L
authors: Vieder
authors: G
authors: G
authors: Schulz
authors: K
authors: K
authors: Lechner
authors: P
authors: P
authors: Bettelheim
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000628:therapy*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000187:drug effects; D011994:Recombinant Proteins / Q000627:therapeutic use; D012074:Remission Induction
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor